1-cyclopropyl-8-fluoro-6-methoxy-7-((4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid

1-cyclopropyl-8-fluoro-6-methoxy-7-((4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid Struktur
2252446-69-6
CAS-Nr.
2252446-69-6
Englisch Name:
1-cyclopropyl-8-fluoro-6-methoxy-7-((4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
Synonyma:
Moxifloxacin EP Imp.D HCl;Moxifloxacin Impurity D HCl;Moxifloxacin HCl EP Impurity-D;Azilsartan medoxomil impurity288;Moxifloxacin Impurity 9 Hydrochloride (Moxifloxacin EP Impurity D Hydrochloride);1-cyclopropyl-8-fluoro-6-methoxy-7-((4aR,7aR)-octahydro-6H- pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride
CBNumber:
CB14927199
Summenformel:
C21H25ClFN3O4
Molgewicht:
437.9
MOL-Datei:
2252446-69-6.mol

1-cyclopropyl-8-fluoro-6-methoxy-7-((4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid Eigenschaften

Sicherheit

1-cyclopropyl-8-fluoro-6-methoxy-7-((4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid Chemische Eigenschaften,Einsatz,Produktion Methoden

1-cyclopropyl-8-fluoro-6-methoxy-7-((4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


1-cyclopropyl-8-fluoro-6-methoxy-7-((4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 20)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Hangzhou Huarong Pharm Co., Ltd.
571-86758373 +8613588754946
sales@huarongpharm.com CHINA 3149 58
China National Standard Pharmaceutical Corporation Limited
+8615391658522
overseasales@yongstandards.com China 11927 58
S.Z. PhyStandard Bio-Tech. Co., Ltd. 0755-4000505016 13380397412
3001272453@qq.com China 5056 50
Beijing Comparison Pharmaceutical Technology Co., Ltd 010-010-52878169 15801002657
sales@bjcomparison.com China 4919 58
Wuxi Zhongkun Biochemical Technology Co., Ltd. 0510-85629785 18013409632
sales@reading-chemicals.com China 15185 58
Shanghai Kewel Chemical Co., Ltd. 021-64609169 18901607656
greensnown@163.com China 9911 50
Guangzhou Dreampharm Biotechnology Co., Ltd. 020-36607679 17825480238
3008233717@qq.com China 9919 12
Jinan Ruisi Pharmaceutical Technology Co., LTD 0531-69900633 18340090523
changyuan20@163.com China 2316 58
Cato Research Chemicals Inc. 020-81215950 4000-868-328
customer@uwalab.com United States 10413 58
Wuxi Helen Biotechnology Co., Ltd., 0510-85629785 18013409632
sales@reading-chemicals.com China 14081 58

  • Moxifloxacin EP Imp.D HCl
  • 1-cyclopropyl-8-fluoro-6-methoxy-7-((4aR,7aR)-octahydro-6H- pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride
  • Azilsartan medoxomil impurity288
  • Moxifloxacin Impurity 9 Hydrochloride (Moxifloxacin EP Impurity D Hydrochloride)
  • Moxifloxacin Impurity D HCl
  • Moxifloxacin HCl EP Impurity-D
  • 2252446-69-6
Copyright 2019 © ChemicalBook. All rights reserved